{"nct_id":"NCT05267600","title":"A Phase 2/3 Study of Efgartigimod PH20 SC in Adult Participants with Bullous Pemphigoid","status":"COMPLETED","status_verified_date":"2024-10","start_date":"2022-06-09","start_date_type":"ACTUAL","primary_completion_date":"2024-09-13","primary_completion_date_type":"ACTUAL","completion_date":"2024-09-13","completion_date_type":"ACTUAL","phases":["PHASE2","PHASE3"],"tickers":["ARGX"]}